Leaflet NEOSPECT 47mcg kit for radiopharmaceutical preparations
Indicated for: diagnostic imaging
Route of administration: injectable
Substance: Tc 99 m - depreotide (contrast agent)
ATC: V09IA05 (Various | Tumour detection | Technetium (99mtc) compounds)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Tc-99m-depreotide is a radiopharmaceutical used in medical imaging to evaluate solitary pulmonary nodules. It binds to somatostatin receptors, which are expressed in certain types of tumors, allowing them to be visualized through scanning.
The medication is administered intravenously, and images are obtained using a gamma camera. It is important for patients to follow the doctor's instructions before and after the procedure.
Patients should be aware of potential adverse reactions, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.
Side effects are rare but may include allergic reactions, nausea, or skin rashes. Patients should be informed of these risks before the procedure.
General data about NEOSPECT 47mcg
- Substance: Tc 99 m - depreotide
- Date of latest medicines list: 01-07-2013
- Product code: W07052001
- Concentration: 47mcg
- Pharmaceutical form: kit for radiopharmaceutical preparations
- Quantity: 1
- Product type: Original
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.